Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2837083 | Cardiovascular Revascularization Medicine | 2014 | 8 Pages |
Abstract
Over the last decade, the introduction of drug-eluting stents has dramatically reduced restenosis and the need for repeat revascularization after implantation of metallic stents. Numerous concerns still remain, however, because of their permanent nature. Thus, the concept of bioresorbable temporary scaffolds composed of biocompatible materials has emerged as a potential alternative to permanent metal stents. Here we focus on metal alloys & discuss preclinical and clinical experiences with bioresorbable metal scaffolds.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Medicine
Authors
Hironori Kitabata, Ron Waksman, Boris Warnack,